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Craniofacial reconstruction may be a necessary treatment for those who have been affected by trauma, disease, or pathological
developmental conditions. The use of stem cell therapy and tissue engineering shows massive potential as a future treatment
modality. Currently in the literature, there is a wide variety of published experimental studies utilising the different stem cell
types available and the plethora of available scaffold materials. This review investigates different stem cell sources and their unique
characteristics to suggest an ideal cell source for regeneration of individual craniofacial tissues. At present, understanding and
clinical applications of stem cell therapy remain in their infancy with numerous challenges to overcome. In spite of this, the field
displays immense capacity and will no doubt be utilised in future clinical treatments of craniofacial regeneration.
1. Introduction
The human body is capable of phenomenal repair; however
this process is flawed; the swift production of scar and fibrotic
tissue closes wounds rapidly but prevents proper recovery of
function. Regenerative medicine is a rapidly expanding field
concerned with “the process of creating living, functional
tissues to repair or replace tissue or organ function lost due
to age, disease, damage, or congenital defects” [1]. Attempted
regeneration of physiological structures is concerned with
the use of progenitor and stem cells, tissue engineering, and
scaffolds as well as use of cellular signals [2, 3].
This paper provides a brief introduction to stem cell
therapy before outlining such stem cell based regeneration
of craniofacial tissues, in a tissue type based fashion. The
sections are divided into mineralised tissues, dental tissues,
soft tissues, sensory tissues, and exocrine glands. These
sections are then further divided into subsections discussing
stem cell therapy in regard to each of the individual tissue
types. Following the dialogue of stem cell tissue regeneration
is a brief paragraph conferring the frontier of stem cell
therapy and what upcoming research may discern.
(1) StemCell Source and Type. Stem cells are a cell type capable
of self-renewal and natural or induced differentiation into
multiple mature cell types [4]. Tissue engineering harnesses
these unique characteristics in order to regenerate functional
aesthetic tissues [5]. The stem cell source and characteristics
of the cell are hugely relevant to its ability to regenerate the
tissue of choice. SCs are classified by their differentiation
potential, their tissue, and individual of origin (Table 1).
Classifying stem cells by origin involves firstly defining cells
by the individual they were obtained from and then from
their native tissue.
Choosing a stem cell type for regenerative purposes must
involve careful consideration of source and characteristics in
order to maintain the cells natural propensity and differen-
tiation potential; however setting strict criteria is idealistic
and stem cell selectionmust include factors such as feasibility,
expansion potential, teratogenicity, andmorbidity of harvest.
Adult stem cells are immunosuppressive and can be
obtained with relative ease, however not without their draw-
backs. Adult stem cells are difficult to expand ex vivo and
have limited differentiation abilities [6, 7]. The majority
of craniofacial structures derive from mesenchymal tissues.
Therefore mesenchymal stem cells (MSCs) are of major
interest in regenerating damaged or diseased craniofacial
structures [4]. MSCs can be obtained from a wide variety of
tissues such as bone marrow cultures, adipose tissue, muscle,
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Table 1: Methods of stem cell classification.
Stem cell classification
Method of classification Source Origin Differentiation potential References
1 Autogeneic Embryonic Totipotent
[6]
2 Allogeneic Foetal Pluripotent
3 Xenogeneic Perinatal Multipotent
4 Adult Oligopotent
5 Induced Unipotent
DFPCs
SHED
SCAP
PDLSCs
DPSCs
GMSCs
Figure 1: Illustrated are the separate origins of dental stem cells.
skin, and PDL [8]. MSCs obtained from sites other than
bonemarrow show similar characteristics, for example, ASCs
which possess relatively analogous multipotent characteris-
tics of BM-MSCs but less morbidity from extraction and can
be obtained in much larger quantities leading to less ex vivo
expansion [9].
Mesenchymal stem cells of dental tissues are of neural
crest cell origin and possess particular relevance to regen-
eration of the craniofacial region as they have a shared
embryological origin [1]. Dental stem cells consist of Den-
tal Pulp Stem Cells (DPSCs), Stem Cells from Human
Exfoliated Deciduous (SHED) teeth, Stem Cells from Root
Apical Papilla (SCAP), Periodontal Ligament Stem Cells
(PDLSCs), Dental Follicle Precursor Cells (DFPCs), andGin-
giva Derived Mesenchymal Stem Cells (GMSCs) (Figure 1)
[4, 10].
Dental stem cells have displayed excellent pluripotency
with the ability to differentiate into endodermal,mesodermal,
and ectodermal tissue lineages providing huge regenerative
scope. DPSCs may be harvested relatively noninvasively and
have shown the ability to differentiate into a wide variety
of tissues such as insulin producing pancreatic islet-like
aggregates which may present valuable use in the treatment
of diabetic children. DPSCs have also shown the ability to
differentiate into hepatocyte like cells and to improve cardiac
function in a murine infarct model [10]. Further proof of
the value of dental stem cells in regenerative medicine was
demonstrated by the differentiation of DPSCs into smooth
muscle cells which holds great promise in noninvasive
bladder tissue engineering but may easily be translated to
other tissues such as gastrointestinal or respiratory tracts [11].
Indeed, dental stem cells possess a wide and diverse range of
regenerative possibilities (Table 2).
The differentiation potential of a stem cell type dictates
its applications within the regenerative field. Nonadult stem
cells possess broader differentiation potential relating directly
to more powerful regenerative characteristics [6]. Embryonic
stem cells are totipotent meaning that they have the capacity
to differentiate into embryonic and extraembryonic tissues.
Despite possessing massive regenerative potency, their rel-
evance is limited due to difficulties in accurate manipula-
tion towards a particular cell lineage and by chromosomal
instability of stem cell cultures in vitro. The extended in
vitro culture time of these cell types results in a greater
likelihood of structural chromosomal abnormalities leading
to undesirable consequences in vivo such as teratoma or
teratocarcinoma formation [6, 12]. There are also numerous
ethical and regulatory issues governing the use of embryonic
stem cells [6]. Foetal and perinatal stem cells display limited
expansion and decreased potency compared to embryonic
stem cells; however harvesting such cell types is somewhat
less controversial [6].
To overcome some of the barriers of adult and nonadult
stem cell sources, induced pluripotent stem cells were
developed. These are terminally differentiated somatic cells
which are generated via genetic reprogramming to revert
back to a plastic multipotent cell type. These stem cells
possess unlimited expansion opportunities in vitro and may
differentiate into cells of any tissue type [6]. While studies
have shown iPSCs to be hugely promising, more research
is needed to optimise their reprogramming to prevent an
immune response. Indeed while all stem cell types have
limitations, there is much on-going research on controlling
pathways and cell differentiation behaviour at a molecu-
lar level to improve characteristics which will aid their
regenerative characteristics and reduce their tumourigenicity
[6, 12].
While the harvesting and manipulation of stem cells
have shown intimidating promise in the field of regener-
ative medicine, there may arguably be a more efficacious
method of manipulating the stem cells already present in
the host. Intrinsically controlling stem cells through the
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Table 2: The different types of dental stem cells and their potential applications in regenerative medicine are displayed.
Dental stem
cells Potential applications References
DPSCs Dentine-pulp regeneration, PDL regeneration, and nonoral tissue regeneration, for example,bladder tissue engineering [4, 10, 85]
SHEDs Dentine-pulp regeneration, craniofacial bone regeneration, neural tissue regeneration, andnonoral tissue regeneration, for example, hepatocyte-like cells [10, 35, 93]
SCAPs Dentine/bone regeneration, continued root formation, and bioroot engineering [10]
PDLSCs Periodontal regeneration [10, 62–64]
DFPCs Tooth root regeneration [10]
GMSCs Wound healing and immunomodulatory therapies for inflammatory disease [10]
use of local growth factor delivery and planned control of
signalling pathways allows for increased native stem cell
migration and improved healing times without the need
for invasive harvesting procedures. The use of growth fac-
tors and other small molecules can optimise the healing
process through early activation of repair mechanisms and
suppression of harmful inflammatory or immune responses
[13, 14]. Optimising native stem cell populations occurs
through intelligent growth factor manipulation directing cell
homing and guiding the stem cell niche [13, 14]. Cell homing
consists of supplying factors at the correct time to support
proliferation, differentiation, and migration of SCs with the
aim of improving endogenous stem cell movement to the
injury site. Another technique is the targeting of the stem
cell’smicroenvironmentwith direct delivery of growth factors
resulting in increased SC motility, division, and maturation
rates [13, 14].While thesemethodsmay present less treatment
morbidity, they may be limited by decreased native stem cell
populations, therefore supporting the idea of a combination
therapy approach in order to obtain the most effective
treatment results.
(2) Harnessing Scaffolds and Biomaterials to Improve the
Regenerative Capacity of Stem Cells. The actions of cells
are entirely dependent on their surrounding cells and their
extracellular matrix. Cell-ECM interactions govern migra-
tion, proliferation, adhesion, and even gene regulation. The
use of scaffolds and biomaterials in tissue engineering and
regenerative medicine allows us to influence cells in such a
way as to increase their regenerative capabilities. Through
biomaterial manipulation to effectively mimic the specific
ECMproperties, it is possible to synergistically drive stem cell
fate towards a desired lineage. Intelligent biomaterial design
should aim to closely mimic the microenvironment of its
desired physiological niche in order for stem cells to deduce
the instructive effect of the biomaterial and hence follow its
desired cell lineage. Stem cells will detect the specificmaterial
properties of a biomaterial and code for specific biochemical
signals affecting its regenerative properties and ultimate
fate [15]. Therefore scaffold properties such as topography,
chemistry, porosity, material choice, and biocompatibility
hugely affect biomaterials regenerative capabilities.
Currently it is widely accepted that the cell-substrate
interface is the gateway through which cell lineage is decided
upon. Biomaterials harness this gateway through altering
topography and chemical structure to direct stem cell adhe-
sion, migration, differentiation, and proliferation. Material
surface topography may be altered via various methods to
provide the micro- or nanotopographical surface roughness
and distribution desired to direct cell lineage. Studies have
shown stem cells to align and orientate themselves depending
on topography [16]. Surface topography may also be altered
through various coatings such as laminin or polylysine
mimicking the architecture of the basementmembrane to aid
in terminal differentiation of stem cells. Surface coatings also
allow for a combined approach utilising materials of suitable
mechanical properties to be layered with a biomaterial of
suitable chemical properties. The surface area of the cell-
substrate interface is directly affected by the relative porosity
of a material. A highly porous communicating geometry
will allow for cellular penetration into the scaffold, uniform
distribution, and angiogenesis [15, 16]. Pore manipulation is
hugely important in scaffold design as it allows communica-
tion to the native tissues. Effective pore design should allow
for cellular migration, neovascularisation, and the diffusion
of substrates and nutrients to fuel stem cell activity.
The biocompatibility of a scaffold material is essential
to its function and successful application [17]. It is critical
that scaffold implantation causesminimal biological response
which may upset the artificial stem cell niche and hence
hinder the regenerative process. Biocompatible scaffolds
must also effectively mimic host tissues in order to allow
native cellular activity and signalling without interruption.
For obvious reasons long-term presence of a scaffold is
hardly ideal; therefore degradability of biomaterials is a highly
attractive characteristic. Scaffold degradation must be a con-
trolled process, occurring at a defined known pace matching
tissue growth rates, while releasing nontoxic products that are
safelymetabolised without causing any form of inflammatory
response [15, 18]. As the degradation rate of many polymeric
scaffold materials is well understood, it is possible to entrap
molecules into the biomaterial so that they may be passively
released at the required site at a defined rate. This property
has huge applications for stem cell therapy as it allows for
modulated drug delivery systems and the incorporation of
specific growth factors to target specific stem cell lineages
[19].This intelligent incorporation of bioactivemolecules into
scaffolds presentsmany advantages such as increasing control
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over regeneration as well as increasing the functionality
and strength of the final tissue [20]. Growth factors can be
sequestered into scaffolds by two main techniques, chemical
attachment or physical encapsulation [20]. Each of these two
techniques allows for a localised interaction between the
desired cells and the entrapped growth factors to influence
differentiation for the targeted expansion of a specific stem
cell lineage [20].
There is an ever increasing array and variety of scaffolds
being invented and innovated upon.Themajority of scaffolds
used in tissue engineering and regenerative medicine tend to
be polymer based as they can form strong rigid structures but
eventually degrade intomonomers whichwill bemetabolised
or excreted. Polymers can also be modified by the addition of
substances related to the particular tissue being regenerated.
An example of this is the addition of hydroxyapatite and
tricalcium phosphate to form a tough composite/polymer
hybrid scaffold intended for bone regeneration [18]. This
substance has improved biocompatibility and buffers the
acidic pH during resorption which would otherwise inhibit
the healing process [18]. However this is just an example and
there is a wide array of scaffold materials and fabrication
techniques available and being experimented upon, each
possessing its own unique characteristics and advantages.
Therefore evaluation of scaffold type for tissue regeneration
may best be performed depending on the discrete clinical
requirements.
2. Stem Cell Based Regeneration of
Mineralised Craniofacial Tissue
2.1. Stem Cell Based Skeletal Tissue Engineering and Activa-
tion of Endogenous Healing through PEMF. Trauma, ablative
surgeries, or congenital deformations can result in reduced
or missing bone. Regeneration of this bone is essential
for proper soft tissue regeneration, muscle function, and
restoration of the facial appearance. Severe damage to the
craniofacial bones not only causes physiological pain but
also may lead to emotional and psychological damage. The
need for craniofacial bone regeneration not only is an ethical
requirement but also is emerging as a hugely remunerative
market with around $390million US dollars spent on cranio-
facial bone trauma in the US alone in the year 2010 [21].
Current treatments of craniofacial bone defects involve
bone grafts and “distraction” techniques. There are several
types of bone grafts available: autogenous, allogenic, and
alloplastic [21]. Autogenous and allogenic bone grafts are
associated with superior osteoconductive properties but are
associated with morbidity of donor site and increased infec-
tion rates. There is much research currently on alloplastic
grafts/scaffolds which consist of forming a synthetic bone-
like matrix which can be produced with the necessary
structural, chemical, and physical qualities cost-effectively
and in abundance. However current materials currently lack
the high levels of integration seen in biological grafts [21].
Distraction osteogenesis (DO) is implicated in the treat-
ment of many congenital craniofacial syndromes resulting
in hard tissue defects such as “maxillofacial microsomia,
micrognathia, and temporomandibular joint ankylosis” and
“midface hypoplasia, maxillary deficiency, zygomatic defi-
ciency craniosynostosis, cleft lip and palate (CLP), and
transverse discrepancies” [22].The technique has been shown
to restore aesthetics in defects; however complications occur
in “upwards of 35%,” formed bone is 40% weaker, and there
is a high morbidity associated with the procedure [1, 4, 23].
The limited outcome obtained by such a procedure highlights
the current potential for regenerative techniques to improve
procedures by lowering patient morbidity and raising the
overall efficacy of the treatment.
Combination techniques utilising stem cells and proven
classical techniques possess potential in bone regeneration
following radiotherapywhich can induce degradation of bone
and hinders wound healing [24]. A study carried out by
Deshpande et al. shows that the BMSC/XRT/DO-treated
animals demonstrated a statistically significant increase in
the Y, UL, and FL in comparison to the XRT/DO group
of 1,009%, 1,679%, and 5,396%, respectively. While this is a
statistically significant improvement it must be noted that it
was noticeably less than the control nonirradiated mandibles
which underwent DO without the use of BMSCs [24].
While using stem cells with current techniques has shown
promise, there is still a high morbidity associated with pro-
cedures such as distraction osteogenesis. Therefore the use of
scaffolds seeded with growth factors and SCs to rapidly repair
skeletal defects is highly anticipated [25]. Scaffolds come in a
variety of forms and act as osteoinductive tissue engineered
extracellular matrix which supports the initial growth and
development of regenerating bone during osteogenesis [25].
Such an example of using stem cell therapy to amelio-
rate skeletal defects was carried out by Farre´-Guasch et al.
They suggested using a 1-step surgical maxillary sinus floor
elevation to allow for dental implants in the treatment of
maxillary atrophy. This treatment aims to decrease expense
and the need for additional surgical intervention which
would increase morbidity. This technique involves liposuc-
tion to obtain a stromal vascular fraction of adipose stem
cells (ASCs) and relevant growth factors (BMP-2) which
are then seeded onto a calcium phosphate ceramic scaffold
which is then injected into the osseous defect.This technique
could provide a viable, more efficient method of treating the
increasing prevalence of maxillary atrophy [26].
Stem cell usage has enormous potential to improve cur-
rent treatment of congenital craniofacial defects such cleft lips
and palates, craniosynostosis, Treacher Collins syndrome,
and Pierre-Robin syndrome. Cleft lips/CLP represent ∼50%
of all craniofacial congenital defects, each case requiring
complicated treatments from a multidisciplinary team. Indi-
viduals afflicted by clefts exhibit decreased alveolar bone
growth and decreased sagittal maxillary growth [27]. Com-
mon treatment of this defect involves maxillary advancement
and alveolar bone grafting; however these treatments while
effective have their disadvantages. Additionally the use of
scaffolds or alloplastic grafts is normally unsuitable for
treatments in growing children as fixed appliances do not
evolve with the surrounding growing tissues [27].
Reconstructing craniomaxillofacial hard tissue defects
is an extremely challenging objective; therefore inclusion
of stem cell therapy to aid treatment outcome is entirely
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necessary. Using ASCs and in some cases supplemental BMP-
2, Sa´ndor et al. sought to reconstruct cases of severe frontal
sinus infection in need of obliteration, cranial defects in
need of a cranioplasty, andmandibular defects resulting from
recurrent ameloblastomas in need of resection and chronic
nasal septum perforations [28]. Many of the cases have had
previous conventional treatments which were regarded as
unsuccessful.The patients who underwent frontal sinus treat-
ment displayed no recurrent infection and “remarkable” bone
formation and remained asymptomatic. Treatment of the
cranial and mandibular defect cases was successful without
presenting any complications. Two of the 3mandibular defect
patients then opted for implants which were successfully
osseointegrated and managed in masticatory loading [28].
This study relatively uniquely also examined the cell markers
of their adipose aspirated to ensure it was of mesenchymal
origin and not of haematopoietic and angiogenic origin.
This ensured a high commitment to forming tissues of
a mesenchymal origin (i.e., bone) and may have been a
controlling factor in these studies [28].
While the following techniques have all shown posi-
tive impacts on healing there is still morbidity associated
with undertaking an invasive surgical approach to encour-
age healing. An interesting technique which is becoming
increasingly accepted in mainstream medicine is the use
of low-frequency pulsed electromagnetic fields (PEMFs).
This treatment option is attractive as it is noninvasive and
painless; PEMFs work through creating an electrical field of
1–100mV/cm to induce bone and vascular growth through
increased native growth factor expression [29]. Controversial
variable results have been obtained regarding the use of
PEMFs on bone regeneration; however recent results are
beginning to show that PEMF treatment is becoming a viable,
effective, and feasible treatment option [30].
The feasibility of this treatment combined with the
elimination of infection risk certifies PEMF as an extremely
attractive craniofacial treatment option to reduce healing
times, support the reconstruction of critical sized osseous
defects, and so forth [31]. Experimentation was carried out
using a high frequency PEMF to stimulate the differentiation
of immortal osteoprogenitor cells from the calvaria of CD1
mice in vitro. While the underlying mechanisms behind
PEMF enhanced bone regeneration are not entirely clear,
this study has been able to show a correlation between the
use of high frequency PEMF and a time related increase in
various different osteogenic promoters. The use of immortal
mice calvarial cells illustrates how PEMF may become a
potential treatment option for craniofacial bone regeneration
as embryological origin did not appear to be a changing factor
[31]. However more research is required on in vivo animal
models for more conclusive results to be drawn.
Current treatment of mandibular factures involves sur-
gical intervention or interdental wiring. Both practices are
associated with high morbidity; therefore the use of PEMF
is ideal to reduce fracture healing time and the associated
morbidity. Abdelrahim et al. investigated the clinical effects of
PEMF on mandible fracture healing. Fractures were reduced
and maxillomandibular fixation was carried out using arch
bars and surgical wiring. PEMF was found to significantly
increase bone density, reduce resorption, and decrease pain
intensity [32]. This study highlights how PEMF could be
a very viable treatment option for improving healing rates
in craniofacial fractures. However this study falls short on
a number of levels such as a small patient group, patients
suffering from postoperative infection, and patients under-
going incomplete treatment. Larger treatment groups and
more randomised control trials are needed to truly analyse
its effectiveness and feasibility [32].
The installation of dental implants can be a complicated
morbid procedure especially in cases complicated by disease
or low bone levels; therefore there is much interest in
methods of improving the osseointegration of implants. Due
to PEMFs promotive effect on osteogenesis and osteogenic
differentiation and the efficacy of its use on the mandible,
Wang et al. set out to determinewhether PEMFcould result in
the increased osseointegration of different types of titanium
dental implants. The experimental PEMF group displayed
improvements in the following areas: protein adsorption, cell
adhesion, cell proliferation, cell morphology, ALP activity,
and ECM mineralisation. Analysis of gene expression shows
that PEMF has a stimulatory effect on the expression of
all osteogenesis related genes [33]. This experiment shows
PEMF to be a powerful tool, capable of greatly enhancing
biocompatibility and osseointegration in vitro through cel-
lular manipulation and gene regulation. Wang et al. discuss
the fact that this increase in compatibility could be due to
the PEMF changing the electrical potential of the implant
surface which could possibly affect polarisation of the cell
membrane enhancing adsorption [33]. The results of this
study suggest that PEMF could be a potential accomplice to
dental implant treatment where poor integration may be of
concern; however further in vivo experimentation is needed
to evaluate efficacy.
The discussed studies using MSCs and PEMF have
shown encouraging results. Experimental studies are now
also beginning to investigate the use of dental stem cells in
repairing osseous defects with extremely promising initial
results. Moshaverinia et al. reported that SHED and DPSCs
had equal results to MSCs when attempting to regenerate a
significantmandibular osseous defect in a caninemodel. Also
suggested were comparable immunosuppressive activity of
the dental stem cells and the fact that paediatric SHED from
offspring could be used in treatment of parental defects [34].
Other dental stem cell sources such as PDLSCs and GMSCs
present with excellent accessibility but have been shown to
possess poor osteogenic capacity compared to BM-MSCs
[35]. Consequently future studies aiming to use dental stem
cells to accelerate craniofacial skeletal regeneration should
concentrate on the use of DPSCs due to easy accessibility
and strong osteogenic properties [36, 37]. However research
is required to determine whether DPSCs possess enough
osteogenic potential to warrant their use over BM-MSCs.
2.2. Stem Cell Based Joint Regeneration, a Possibility Worth
Investigating? The reconstruction of craniofacial mineralised
tissues is not just limited to bone but may also have appli-
cations in osteochondral defects. One such area in need of
regenerative solutions is the TMJ. TMJ disorders cover a wide
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range of conditions occurring with a high incidence rate with
75% of the population showing one or more signs of joint
dysfunction and 33% of the population possessing at least one
symptom such as joint pain [38]. Native healing of the TMJ
is reduced due to poor vascularisation linked to diminished
healing, hypocellularity, and decreased progenitor cell pop-
ulations. The high prevalence and associated high morbidity
of TMJ disorders strike the need for regenerative treatment
options [38, 39]. However treatment of TMJ disorders is com-
plicated by several factors such as lack of explicit causation,
the close integration of tissues, prevention of adhesion of
structures, and finally the ability for a regenerated structure to
sustain substantialmasticatory and kinetic stresses [4, 38, 39].
Similarly to bone regeneration, most experimental stud-
ies have concentrated on the use of mesenchymal stem cells
to regenerate the osseous structures of the TMJ. Re’Em
et al. developed a MSC seeded bilayer hydrogel system con-
taining osteoinductive BMP-4 and chondroinductive TGF-
𝛽1 in respective layers to implant in New Zealand white
rabbits [40]. MSCs displayed the ability to differentiate into
osteoblasts and chondrocytes in their respective hydrogel
layers which then developed into separate distinguishable
tissues. The creation of a multilayered TMJ-like construct is
a step towards functional TMJ regeneration; however, much
more research is required before mechanically satisfactory
constructs could be successfully placed in vivo [40, 41].
Using a similar model to Re’Em et al.’s, an in vivo
model of a dental stem cell seeded hydrogel system was
successfully carried out using GMSCs and PDLSCs in an
in vivo mouse model to stimulate ectopic chondrogenic
regeneration. The GMSCs and PDLSCs were encapsulated in
a TGF-𝛽1 ligand before being seeded into the RGD coupled
alginate which was then implanted into the dorsal surface
of beige nude mice [42]. Analysis revealed differentiation
into cells morphologically similar to chondrocytes and the
endogenous release of chondrogenic growth factors, BMP-4
and FGF-2 resulting in the deposition of cartilage-like tissues
containing proteoglycan and collagen type II. PDLSCs were
noted as having even higher production of collagen type II
than BM-MSCs, therefore providing support to the notion
that stem cells of a neural crest origin may be preferential
candidates for TMJ regeneration [42].
However regeneration of the TMJ is not solely concerned
with the mineralised structures of the joint. The TMJ is
composed of multiple tissue types all interacting to allow
movement of the bicondylar hinge. One of these components
is the meniscus or disc which acts to reduce friction and
provide cushioning between the mandible and the articu-
lar fossa. In TMJ defects this disc is commonly displaced
and/or damaged. Current treatments of TMJ discs involve
removal and placement of artificial prostheses; however a
review carried out by Hagandora and Almarza dismisses the
placement of artificial TMJ claiming few long-term benefits,
the possibility for further degeneration, and failure to treat
joint dysfunction. Tissue engineering techniques have the
potential to become a more suitable solution for repair of
TMJ defect and regeneration of the damaged TMJ [43].
One of the initial regenerative attempts using stem cells was
carried out using TMJ derived synovial stem cells seeded
onto a fibrin/chitosan scaffold hybrid implanted into nude
mice. The experimental construct displayed improved cell
adhesion and proliferation as well as increased expression of
GAGs and collagen type 1 [44]. This pilot study suggests a
potential treatment model for TMJ disc perforation; however
more animalmodels are needed to discover themost effective
scaffolds and stem cell choices.
Future studies should concentrate on exploiting a stem
cell type with both chondrogenic and osteogenic properties
which can be held in an engineered construct containing
molecules to direct stem cell fate towards the desired linage
in a spatial arrangement such as the study carried out by
Re’Em et al. Dental stem cells have been shown to possess
both chondrogenic and osteogenic properties and future
research may reveal them as an attractive stem cell source
for TMJ reconstruction [11, 42]. Certain challenges must be
overcome before such therapies have any clinical applications
such as the fact that guaranteeing constructs can sustain the
substantial mechanical and kinetic forces generated during
functioning and the ability to facilitate natural remodelling
of the joint postoperatively [4].
3. Potential Applications of Stem Cell
Therapy in Dentistry
3.1. Tooth Regeneration, the Ultimate Goal of Dental Science.
Teeth play a pivotal role in the oral cavity affecting all major
oral functions. Any loss of teeth can affect an individual’s diet,
social habits, psychological health, communication skills,
and so forth. Cases where violent trauma or oral neoplasm
excision has occurred are in great need of a suitable tooth
regenerative strategy. Also in severe need of a regenerative
strategy are patients suffering from congenital defects such
as amelogenesis, ectodermal dysplasia, and Rieger syndrome
[45]. Tooth regeneration presents similar challenges to that
of bone regeneration such as the need to sustain considerable
forces. However, to properly recreate a functional tooth, there
is the additional challenge of regenerating multiple hard and
soft tissues in harmony. While challenging, regeneration of
dental structures is a necessary progression from current
treatments which are imperfect and unequal to that of the
natural tooth. Common restorative procedures have high
failure rates which result in a continual cycle of further
tooth destruction. These treatments may also have per-
sonal requirements which are commonly unavailable such as
unsuitable bone levels for dental implants.
An interesting yet ambitious method of tooth regenera-
tion was developed by Sonoyama et al. In their study they
built up a bioroot formed of apical papilla stem cells seeded
into the HA-TCP complex coated in a “Gelfoam” containing
PDLSCswhichwas then implanted into a lower incisor socket
of a mini pig [46]. After 8 weeks the bioroot had formed
cementum and Sharpey’s fibres attachment; finally after 3
months, a porcelain crown was fitted to the bioroot [46].
While the crown showed sufficient strength to support crown
and carry out normal masticatory function, it still did not
possess the loading strength of a comparable natural tooth
and their method of cell delivery has low clinical potential
due to costs [46, 47]. However the employment of multiple
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stem cell types to regenerate their propensive structures may
be necessary in future studies to acquire a model with clinical
suitability.
Kim et al. attempted a more feasible method using cell
homing to regenerate humanmandibular molars in Sprague-
Dawley rats. This was carried out by implanting a 3D printed
PCL-HA scaffold with microchannels seeded with BMP-7
and SDF-1 into the dorsum of the rats. BMP-7 was chosen
for its ability to encourage mineralisation, while SDF-1 was
selected for its ability to bind to the chemokine receptor
CXCR-4 which is present on endothelial cells and bone
marrow SCs/progenitors [47, 48]. This study significantly
generated alveolar bone, pulp, cementum, PDL, and dentine,
resembling tissues which were richly vascularised, and it
proved that cell homing could be a viable future method of
tooth regeneration [47, 48].
Despite Sonoyama et al. andKim et al. showing successful
tissue regeneration, they failed to mimic the complex natural
tooth tissue composition and structure. Oshima et al. sought
to overcome this by bioengineering a molar tooth germ.
The construct would consist of epithelial and mesenchymal
components placed in a plastic size control device to implant
in the subrenal capsule of a mouse where it would progress
and develop [49]. Once established the bioengineered tooth
unitwas implanted into an extensive alveolar defect generated
in the lower molar region of a mouse where it possessed
proper occlusion. Surface hardness of the bioengineered
tooth tissueswas comparable to that of a normalmousemolar
[49]. Experimental orthodontic procedures demonstrated
alveolar remodelling with the presence of osteoblasts and
osteoclasts on the respective tensive and compressive sides
indicating proper PDL integration. Successful integration of
the bioengineered toothwas shown through the development
of nerves and blood vessels to the pulpal region and some
regeneration of the alveolar bone defect [49].
Oshima et al.’s work illustrates a potential viable model
for whole tooth regeneration. The integration and effective-
ness of this model could potentially be further increased
by developing a method of tooth germ development in a
supersaturated environment and the incorporation of growth
factors to improve alveolar bone regeneration. It is essential
that alveolar bone regeneration remains closely associated
with tooth regeneration as the future clinical uses of tooth
regeneration will remain adjunctive to treatment of peri-
odontal disease.
Honda et al. also attempted to overcome the challenges of
whole tooth regeneration using a unique scaffold construct
and cell seeding. Postnatal epithelial enamel organ cells
and mesenchymal dental papilla cells were obtained from a
porcine developing 3rdmolar tooth in early crown formation
[50]. The experimental construct was formed by seeding
the mesenchymal cells onto a collagen sponge scaffold and
then later seeding the high density epithelial cells atop the
mesenchymal cells to allow for direct cell-cell interactions
[50]. After implantation into immunocompromised rats,
tooth germ structures were apparent in all implants with
odontoblast and ameloblast-like cells secreting enamel- and
dentine-like structures. The concept of this study was aiming
to illustrate that, with sufficient cell-cell communication,
tooth shape and tooth number can be controlled without the
need for complex signalling factors or intervention. These
cell-cell interactions are thought to be responsible for the
increased rate at which the regenerated tooth developed [50].
This study illustrates the need to further investigate
macro- and micromolecular signalling mechanisms between
these tissues in order to maximise both the efficiency and
structure of the final product. Furthermore future studies
should also aim to develop intelligent scaffolds incorporating
growth factors to encourage cell lineage towards its desired
fate while controlling for the appropriate amount ofminerali-
sation in each tissue type. Growth factor incorporation seems
to be a necessity for whole tooth regeneration due the varied
tissues and complex nature of signalling involved.
Regeneration of the whole tooth is important where
teeth are missing or damaged beyond repair. However in
many cases only parts of the tooth are damaged such as in
trauma, caries, and pulpitis, and efforts must be made to
develop regenerative strategies for treatment applicable to
these defects. The tooth and in particular the dentine-pulp
complex possess natural regenerative reactions when placed
under threat such as the recruitment of progenitor cells, that
is, the formation of reparative dentine and remineralisation.
Even current techniques such as the use of calcium hydroxide
in pulp-capping are related to reparative dentinogenesis.
While the tooth possesses an intrinsic protective ability to
defend itself against attack, it is often insufficient. Therefore
with further elucidation of the chemotactic driving signals,
it may be possible to therapeutically exploit and manipulate
this mechanism to provide an efficient clinical treatment
option [51]. Another possibility which was discussed was the
harvesting of adult dental stem cells from locations elsewhere
in the body and having them differentiate into odontoblast-
like cells to direct dentine bridge formation [52].
While the dental pulp complex has some innate regen-
erative capabilities, enamel does not due to the loss of
its formative cell, the ameloblast, upon eruption. Current
restorative treatments involve the use of engineeredmaterials.
These materials possess similar but inferior mechanical and
physical characteristics resulting in inadequate longevity.
Regenerative techniques could potentially one day provide
us with “biobonded” enamel/dentine inlays and eliminate
the need for secondary restorations. New clinical techniques
could culture epithelial cell rests of Malassez in the aim of
differentiating them into ameloblasts, which could produce
sound enamel when deposited onto an appropriate scaffold
[52].
Using cells from a newborn mouse enamel organ and
ameloblast-like cells, Huang et al. sought to use stem cells
to develop enamel-like structure. These cells were cultured
onto “a branched peptide amphiphile containing the RGD
peptide epitope” to facilitate stronger adhesion and due
to its ability to self-assembly into nanofibres [52, 53]. The
peptide amphiphile and cell cultures were then aggregated
and implanted into the enamel organ of a mouse incisor [53].
Analysis of the in vivo and in vitro experiments carried out
revealed expression of enamel matrix proteins such as amelo-
genin, differentiation of enamel organ cells into ameloblasts,
and increased mineral deposition (only confirmed in vitro)
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[52, 53]. This study provides further support to the use of
dental stem cells for enamel regeneration. However despite
laboratory successes, there is still huge amounts of research
needed before regenerated enamel could ever possess feasible
clinical potential.
3.2. Stem Cell Based Regeneration of Oral Mucosa. The oral
mucosa and periodontal tissues have extraordinary abilities
of self-regeneration, much higher than that of comparable
tissue such as that of the skin. This is thought to be due
to the unique populations of progenitor and stem cells
that exist within its make-up [54]. Oral mucosa possesses
extremely good healing capabilities with reduced scar for-
mation and accelerated healing time due to decreased levels
of inflammatory cells and cytokines, as well as a decrease in
the ratio of TGF𝛽-1 : TGF𝛽-3. While oral mucosa possesses
good regenerative characteristics, there is need for new
regenerative techniques. Current treatments such as skin
grafting have noted morbidities including oral hair growth
and excessive keratinisation, and with increasing rates of oral
cancer and a growing population with increased periodontal
disease susceptibility, there is a definite need for regenerative
treatments concerning oral tissues [55].
One of the primary concerns in regenerative medicine
when attempting to regenerate functional tissue is where and
how to obtain a suitable stem cell population. In the case
of oral mucosa, Davies et al. found there to be an easily
isolatable population of progenitor cells of neural crest cell
origin within the lamina propria of the oral mucosa [54].The
isolation of such a population holds huge potential for the
future of oral mucosa regeneration and indeed regeneration
within the whole craniofacial region. The isolate population
was observed to be multipotent and capable of generating
both mesenchymal and ectodermal cell lineages. Further
research could lead to the generation of a new common
source of progenitor cell isolation due to the cell’s high
proliferative rate in vitro, the lower amount of regulatory
issues concerning adult sources of stem cells, and the low
morbidity of obtaining said cells [54]. Miyoshi et al. sought
to take a different approach to developing an oral mucosal
stem cell population. In their study they presented the case of
using oral fibroblasts over dermal fibroblasts as an alternative
cell population for producing iPSCs. Their research proved
that oral fibroblasts could be easily translated into iPSCs
with less harvestingmorbidity and improved harvest location
healing [56]. Garzo´n et al. have suggested a potential method
of oral mucosal regeneration using WJ-MSCs seeded atop
a stroma containing fibrin and oral mucosa fibroblasts to
induce epithelial differentiation. This construct was then
grafted onto a 2.5 cm2 skin excision on the dorsal surface of
immunodeficient athymic mice. Analysis revealed the pres-
ence of epithelial keratinocytes and well-structured defined
epithelial layers consisting of basal, spinosum, granulosum,
and corneum cell layers. Indeed this displays a credible
treatment option for clinical use in patients with the need for
large areas of oral mucosal regeneration [57].
3.3. Stem Cell Applications in Treatment of Periodontal
Conditions. Periodontal disease is a chronic inflammatory
condition of the periodontium leading to periodontal tissue
destruction and a loss of attachment between the tissues
and the tooth. Loss of alveolar bone, cementum, gingiva,
and the periodontal ligament result in gingival recession,
increased dental sensitivity, and if left uncontrolled, eventual
premature tooth loss. According to the adult dental health
survey of 2009, 66% of the UK population over the age of 55
display some loss of periodontal attachment. Recent studies
have suggested that chronic inflammation of the periodontal
tissues is associated with a number of systemic diseases such
as diabetes, cardiovascular disease, respiratory disease, and
preterm low birth weight [58–61]. Current strategies mainly
employ preventative practices to cease disease progression
and the treatment approaches used clinically have variable
results withminor clinical improvements. Hynes et al. carried
out a thorough review of studies using stem cells in peri-
odontal regeneration covering BM-MSCs, DPSCs, PDLSCs,
SCAP, periapical follicular stem cells, and stem cells from
deciduous teeth.While several stem cell types displayed some
regenerative capacity, unsurprisingly PDLSCs displayed the
greatest capacity for periodontal tissue regeneration with
multiple studies reporting regeneration of alveolar bone,
cementum, and Sharpey’s fibres of the periodontal ligament
[62–64]. Hynes et al. discuss the numerous clinical issues
needed to overcome before clinical translation can arise such
as improved understanding of cell processes and the need
for “large-scale preparation facilities.” While these issues still
persist, Hynes et al. discuss a method for overcoming the
issues involved with accessibility and proliferation in culture
via differentiating iPSCs into MSC-like cells. MSC-like cells
were able to demonstrate significantly increased mineralised
tissue regeneration and the formation of PDL-like tissue in
a rat periodontal defect model; however the study did not
mention whether the cells contributed to the regeneration of
cementum [65].
While using the fenestration type model in laboratory
rats is useful in evaluating and comparing the most effective
possible treatment type, there is a need for more safe clinical
experimentation in humans with periodontal disease such as
that carried out by Feng et al. Autologous periodontal cell
progenitors (PDLPs) obtained from extracted third molars
were seeded into hydroxyapatite and were implanted into
16 deep intrabony defects of pocket depth ≥6mm in 3
male patients. Each patient showed considerably significant
clinical benefit from the procedure with no inflammation in
the treatment area. Analysis of PDLPs compared to PDLSCs
revealed many of the same stem cell properties; however
PDLPs have slightly reduced osteogenic differentiation capa-
bilities. There is a clear need for a well-performed clinical
trial with greater patient numbers utilising PDLSCs to truly
determine the potential viability of this treatment method
[66].
4. Soft Tissue Regeneration
4.1. Stem Cell Use in Cosmetic Dermal Regeneration. Skin
plays a crucial role in regulating body temperature, protection
against infection, synthesising vitamin D, sensation and
appearance, and so forth. Damage to skin of the craniofacial
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region can occur through a number of means, for example,
burns, extensive trauma, and tumours. Defects of the facial
appearance can be damaging psychologically as well as
physiologically as it is our most identifiable feature which
is integral to effective communication. While the skin has
rapid repair mechanisms, the healed product, a fibrous CT
scar loses function, aesthetics, and any lost appendages do
not regenerate [67]. The best most currently used method of
treatment is autologous skin grafts; however the procedure
experiences setbacks such as availability and morbidity of
donor site and scar contracture [1]. Larger procedures suffer
frommore severe flaws such as the need formultiple surgeries
and grafts resulting in noticeable deformities [1].
There is much research on using biocompatible synthetic
and natural polymers in the replacement of autologous skin
grafts [68, 69]. These new forms of dressings have enormous
possibilities in regeneration as they possess the ability to
be seeded with stem cells, growth factors, and skin cells
such as keratinocytes and fibroblasts [68]. Studies carried out
with the use of stem cells within a dermal substitute have
claimed improvements in angiogenesis, collagen synthesis,
and healing time while also showing a decrease in fibrosis
[69]. However there are not yet any studies carried out to
produce a dermal substitute capable of replacing skin grafting
technology [1].
Current skin regenerative technique aims to reduce scar
formation; however with the use of stem cell and regenerative
technology it may one day be possible to simply avoid scar
formation. Jackson et al. discuss the use of MSCs in inhibit-
ing scar formation and their many interactions/properties
which positively influence cutaneous regeneration. Despite
the obvious characteristics such as direct differentiation into
dermal cell types, MSCs have the ability to immunomodulate
T-cell and macrophage activity, reducing inflammation and
promoting fibroregulation.MSCs are also understood to pro-
duce antifibrotic factors while enhancing dermal fibroblast
function promoting the formation of natural extracellular
matrix and a tissue similar to its surroundings [70].
Sabapathy et al. aimed to demonstrate the ability of mes-
enchymal stem cells to attenuate cutaneous scarring via the
use of extraembryonic MSCs obtained from umbilical Whar-
ton’s jelly (WJ-MSCs). The stem cells were then seeded onto
a decellularised portion of amniotic membrane which was
sutured onto the surface of a 1 cm2 full skin excisionwound in
black SCID mice. WJ-MSCs were found to have significantly
increased immunomodulating capabilities in the presence
of proinflammatory compounds compared to typical BM-
MSCs. It is thought that the increased immunomodulatory
mechanisms of the WJ-MSCs are used to augment “Scar-
Free Wound Healing with Hair Growth.” WJ-MSCs and
the decellularised amniotic membrane were also found to
have improved mechanical properties [71]. This method of
preventing scar formation displays impressive results without
any morbid cell harvesting methods.
Recently discovered are leucine-rich repeat-containing
G-protein coupled receptors (LGR) which are present as
transmembrane markers found in stem cells throughout
all epithelial tissues. The recent discovery of this marker
allows for cell isolation and the utilisation of such cells in
the regeneration of epithelial tissue with insufficient stem
cell population [72]. Lough et al. aimed to demonstrate the
regenerative capabilities of these cells through delivering
LGR-6+ cells underneath 3mm2 burn wounds in a mouse
model. Analysis of LRG stem cells effects on gene expression
reveals an increase in the release of factors such as VEGF,
EGF, and other factors related to tissue regeneration [72].
The release of these factors increase angiogenesis, thereby
increasing wound healing time. Analysis reveals that despite
trauma and the process of wound healing the LGR-6+ cells
were still viable therefore lending the idea that the cells have
potential healing much larger defects than the 3mm2 defects
created in this study; however future research will need to
confirm this. Uniquely attributed to LGR stem cells is their
ability to regenerate hair follicles.This characteristic is highly
valuable in regeneration of craniofacial skin due to the desire
to regenerate the aesthetics of the face including facial hair
[72].
The market for the rejuvenation of skin is a huge one and
currently there are many products on the market with huge
amounts being spent on research. Regenerative medicine
is mostly concerned with regeneration of the function and
aesthetics of tissues following disease and trauma; however
with aging, many tissues have a marked decrease in function
and in the case of skin and lose their aesthetic properties.
Therefore we cannot discredit the possibilities of regenerative
medicine in rejuvenation of skin and all its other less
clinical and more commercial possibilities. A study by Harn
et al. tested the use of peripheral blood stem cells (PBSCs)
treated with granulocyte stimulating colony factor (GCSF) to
rejuvenate the skin of Lanyu pigs [73]. Analysis revealed that
the PBSCsmigrated to dermal tissues and increased synthesis
of hyaluronic acid, collagen 𝛽1-integrins, and elastin. This
increase in synthesis of these dermal tissue components has
corresponding effects on its structure such as decreased skin
thickness, reduced wrinkles, and increased suppleness [73].
The results of this study are promising but are limited by the
small sample size and the short analysis time which did not
allow for any long-term analysis.
To define an ideal stem cell population for dermal
regeneration is complicated by the nature and the severity of
the injury requiring treatment. Autologous adult stem cells
may not possess the expansion capabilities to provide an
adequate quantity of cells whereas culturing extraembryonic
stem cells may not be feasible for smaller injuries. Therefore
allogeneic extraembryonic stem cell therapy may present
an ideal stem cell source for widespread burn injuries due
to increased immunomodulatory capacity and increased
proliferation properties [74, 75], while smaller injuries may
benefit from therapy using autologousASCswhichwould not
have to rely on tissue banking but would also benefit from
immunomodulatory properties.
4.2. Regeneration of Fat to Reshape the Face. While replacing
skin and ensuring minimal fibrosis are essential for proper
facial appearance and form, fat plays a substantial role in
aesthetics providing contour and volume to the face. Defects
in facial fat and contour can be due to a wide variety of causes
such as trauma, disease, or surgery. Currently, treatment of
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defects such as lipodystrophy involves fat grafting which has
proven to be a very effective, long-term treatment. While
this tissue is easily harvested and abundant it suffers from
relatively high rates of resorption after surgery depending on
technique [1]. Zhu et al. were able to show that the addition of
adipose derived regenerative cells can double graft retention
and improve quality and angiogenesis [76].
Similar results were found in a study by Koh et al. In this
study 5 patients received ASCs and microfat grafts while the
other 5 patients (the control group) received only microfat
grafts. All patients in the study suffered from Parry-Romberg
disease which causes progressive hemifacial atrophy. Postop-
eratively results weremeasured using a 3D camera and 3DCT
scans. Treatment for all groups was successful with the ASC
groups demonstrating significantly less resorption after graft.
This difference is statistically significant and results in amuch
better graft retention resulting in better aesthetics and amore
efficacious treatment [77].
Adipose stem cellsmay also demonstrate increased reten-
tion when used in adipose transplantation for cosmetic
reasons. Tanikawa et al. aimed to restore proper contour and
volume to 18 patients with craniofacial microsomia using
aspirated fat tissue supplemented with stromal adipose cells.
The stromal adipose cells contain “multiple types of stem and
regenerative cells” which is thought to compensate for the
lower number of such cells present in the aspirated fat when
compared to the integral undisturbed tissue [78]. Cellular
and clinical analysis as well as radiographic assessment of
preoperative and postoperative tissue volume and thickness
was used to determine significance with the experimental
group showing significantly better retention and volume than
the control group. It has been suggested byTanikawa et al. that
the addition of stromal adipose cells contains multiple regen-
erative cell types allowing for better integration, improved
quality, and increasing both angiogenesis and preadipocyte
differentiation [78]. The study also found the cost of adding
the stromal adipose cells to be entirely feasible. The only
limitation to the study was the high dropout rate; however
the remaining patients were found to have no complaints one
year postoperatively.
Several studies have displayed significant success with
improving graft retention via ASCs incorporation; however
a review by Kokai et al. discusses several other studies which
were unable to find any significant differences in appearance
or patient satisfaction [76–79]. However it was mentioned
that this may be due to differences in cell dose efficacy
or in the treatment and refinement of the ASCs prior to
implantation.The review also suggests the use ofmore animal
studies with immune competent animals to determine the
possible immune interactions between the recipient host and
the lipoaspirate [79]. In summary, the use of adipose derived
MSCs may be a wonderful supplement to conventional fat
grafting but prospective research is needed to define its
efficacy.
4.3. Muscle Regeneration and Possible Myogenic SCs. Mus-
cular tissue has many essential visible functions in the
craniofacial region. Its basic function is the production of
contractile forces and elicitingmovement.This basic function
has a wide variety of uses: providing facial expression,
mastication, speech, sight, respiration, swallowing, andmany
more. These activities are essential to a good quality of life;
therefore regeneration of craniofacial muscle would make an
outstanding impact in our treatment of Bell’s palsy, neoplastic
resection, craniofacial trauma, hemifacial atrophy, Moebius,
and congenital deformities [1].
One common problem in many craniofacial abnormali-
ties, particularly cleft lip/palate reconstruction, is recreating
the normal functional capacity of the oral cavity (includ-
ing swallowing, speech, and sucking) due to fibrosis and
poormuscle presence leading to velopharyngeal dysfunction.
Therefore muscle regeneration of the oral cavity, lips, and
palate is imperative to ensure complete functionality and
improve the patient’s quality of life. Currently a suitable
animal model using Sprague-Daley rats for regenerating
palatal muscle following cleft palate has to be outlined but no
current studies have yet been published [80]. Once studies
begin to form they must overcome several key barriers such
as the following:
(1) Poor intrinsic regenerative capacity of palatal mus-
culature poor muscle function of existing palatal
musculature due to disorganisation and lowmyofibre
count.
(2) Fibrosis resulting from surgical intervention impair-
ing and sort of muscle regeneration.
Stem cells seem like an ideal solution to overcoming these
barriers due to their ability to immunomodulate, their stim-
ulation of endogenous healing, and their promotion of fibro-
regulation.
Currently there is much research into the use of different
types of SCs to regenerate muscle, each possessing differing
characteristics (Table 3).
The discussion of which stem cell type is ideally situ-
ated for muscle regeneration similar to other tissues is a
complicated and multifaceted one. The optimal choice of
cell, scaffold, and delivery method has yet to be definitively
discovered, as each method presents with various unique
characteristics.
Clinical trials utilising a promising stem cell choice,
mesoangioblasts, and the supposed most effective method
of stem cell delivery have shown disappointing results [81,
82]. However recent developments are beginning to reveal
light at the end of the tunnel. Through reprogramming
mesoangioblasts to become iPSCs, Quattrocelli hoped that
the cells would safely maintain their myogenic propensity
while presenting all the obvious advantages of iPSCs. In order
to determine whether the myogenic preference would affect
the cells regenerative ability, cells were then differentiated into
mesodermal lineages. Regenerative aptitude was examined
using canine and murine cells in a dystrophic murine model
as well as human cells in vitro. Analysis revealed that the
cells showed the ability to regenerate skeletal striated muscle
with engrafting of both slow and fast twitch muscle types.
These cells also demonstrated successful correction of a
muscular dystrophy murine model with in vivo regeneration
of striatalmuscle, contraction force, and function comparable
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Table 3: This table shows potential SCs for use in muscle regeneration and their positive and negative characteristics.
Stem cell Advantages Disadvantages References
Embryonic stem cells
(ESCs)
(i) Have been shown to improve muscle
function in vivo
(ii) Pluripotent
(i) Research limited by regulations
(ii) Need presence of box genes (Pax-7)
Induced pluripotent stem
cells (IPSCs)
(i) Less regulations
(ii) Pluripotent
(i) More study needed to ensure that
there is no tumorigenic potential
Satellite cells (i) Express Pax-7(ii) Self-proliferating
(i) Difficult to isolate
(ii) Damaged by in vitro culture
Muscle derived stem cells
(MDSCs) (i) Osteogenic and adipogenic [81, 117]
MSCs (i) High ability to differentiate(ii) Modulate inflammation
(i) Need more research before in vivo
studies
Muscle derived CD133+
stem cells
(i) Formed myosin heavy chain
(characteristic of craniofacial muscle)
(ii) Safe and feasible
(i) Myogenesis in vitro requires
additional cell cultures
Mesoangioblasts (i) Angiogenic(ii) Easy expansion in vitro (i) Require factors to improve migration
to a control model. In vitro experimentation using human
cells also exhibited a similar propensity for myogenesis
[83].
Other methods of overcoming the dystrophic mouse
model have also been discussed such as combined ther-
apy utilising stem cell and gene therapy to achieve some
exceptional results. Fibroblasts from dystrophic mice were
reprogrammed to iPSCs which were then supplemented with
microutrophin gene. Myogenic potential was induced by
supplementation of Pax-3 and Pax-7. Following transplan-
tation, utrophin positive myofibres and partial restoration
of the dystrophin glycoprotein complex were observed and
repopulation of the stem cell niche was recorded. Through
the successful combination of gene and stem cell therapy
systemic delivery of utrophin was confirmed resulting in
markedly improved muscle function [84]. This study shows
that many novel solutions exist for muscle regeneration and
much further research is needed. Such models could be
translated to the craniofacial region to provide a wide variety
of potentially exciting future treatment options.
While the regeneration of striated muscle is critical for
future craniofacial regenerative treatments, smooth muscle
regeneration could present value towards vascular repair
and reconstruction of the iris and ciliary muscles of the
eyes. Contrary to the previous studies mentioned, Song
et al. sought to regenerate smooth muscle utilising cells
from the craniofacial region. DPSCs were induced to form
bladder smooth muscle cells using a conditioned medium
and TGF-𝛽1. Effective differentiation was achieved with
the transformed cells demonstrating morphological change
indicative of smoothmuscle cells alongwith the expression of
smoothmusclemarkers such as𝛼-SMA, desmin,myosin, and
calponin [85].While this study concentrated onDPSCuse for
bladder tissue engineering, they highlighted that the cocul-
turemethod has the capacity to guideMSCs towards vascular
smoothmuscle cells and striatedmuscle cells. Both the neural
crest cell origin of DPSCs and the previous successes seen
by this coculture method suggest that this technique could
possess clinical application in the craniofacial region.
In order for muscle regeneration to develop into a clinical
treatment, numerous obstacles must be climbed. All current
stem cell choices for regeneration are limited by certain
complications such as poor expansion (satellite cells), safety
(iPS cells), and a current lack of literature on the topic (dental
stem cells). For dynamic tissues such asmuscle tissue, scaffold
design is paramount for acquiring themaximum regenerative
potential from stem cell therapy. Currently required are new
generations of scaffolds and biomaterials which intelligently
amplify cell activity at a necessary location while engaging
with the host response and native ECM to direct repair.
Innovative materials combined with a greater understanding
and improved manipulation of myogenic stem cells should
provide future trials with amuch greater likelihood of success
[86].
4.4. Stem Cell Based Regeneration of Neuronal Tissues. The
craniofacial nervous system is incredibly complex innervat-
ing multiple discrete tissues and carrying a vast array of
intricate efferent sensory information to the CNS. Damage
to any of the cranial nerves from congenital, idiopathic,
or traumatic means can cause significant morbidities and
loss of facial function. Structures which lose innervation
have the tendency to rapidly atrophy; consequently prompt
regenerative techniques could hold promise reducing tissue
atrophy as well as improving function. The standard proce-
dure now consists of autologous nerve grafts, which present
the complications of nerve sacrifice somewhere else in the
body [87].
Similarly to many tissues the exact ideal stem cell type
for neural regeneration has not yet been discovered. Com-
parison of the neural regenerative capacity of MSCs, ASCs,
and Schwann cells in fibrin nerve conduits in the sciatic
nerve of Sprague-Dawley rats revealed that each enhances
regeneration over the control as expected. However Schwann
cells outperformedMSCs andASCs, which was thought to be
due to the release of neural bioactive factors. Unfortunately
Schwann cells present numerous clinical difficulties such as
culturing in vitro and the need for a biopsy/nerve sacrifice
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which limits their clinical applications until further cell
manipulation is possible [87].
Many studies attempting neural regeneration have begun
incorporating neurotrophic growth factors to enhance bioac-
tive integration and regeneration. Herna´ndez-Corte´s et al.
incorporated vasoactive intestinal peptide (VIP) as it has a
wide range of functions such as vasodilation, immunomod-
ulation, and neuroprotection and previous studies by Rayan
et al. and Zhang et al. were able to demonstrate that VIP
when delivered locally to a transected sciatic nerve was able
to increase remyelination and increase the rate of axonal
regeneration [88–90]. ASCs obtained from Balb/Cmice were
implanted with a lentiviral VIP vector forming ASC-VIP
cells possessing typical MSC characteristics while also being
capable of sustained VIP production greater than synthetic
counterparts. The cell suspension was then implanted into
D1-lactic-𝜀-caprolactone conduits which were subsequently
implanted into the 10mm sciatic nerve defect. Functional
assessment of the ASC-VIP seeded conduit showed sig-
nificantly improved recovery with substantially significant
nerve regeneration and improved myelination. This increase
in nerve regeneration is thought to explain the concurrent
reduced muscle fibre loss in the experimental group [88].
Despite this study showing promising nerve regeneration,
there were no coinciding effects on the targeted muscles and
this was due to misdirection of regenerating nerve fibres and
concurrent innervation of functionally incorrect muscles.
Other growth factors have also shown promise in aiding
neural regeneration. Fibroblast-growth factor (FGF) has been
shown to stimulate proliferation of glial cells and fibroblasts
as well as stimulating angiogenesis [91, 92]. By morphing
mouse iPSCs into primary and successive secondary neu-
rospheres, Ikeda et al. aimed to develop and harvest glial
progenitors. The secondary neurospheres were then seeded
onto a nerve conduit formed of polylactic acid with poly
𝜀-caprolactone incorporated interiorly. Human recombinant
bFGF was then incorporated into gelatin microspheres to
provide a slow release drug delivery system.C57BL6mice had
5mm artificial defects created in the sciatic nerve which were
bridged using the experimental neurosphere/bFGF seeded
conduits [91]. Motor recovery and analysis of neurofilament
positive axons revealed autografting performed significantly
better than the experimental group. However sensory testing
and analysis of S-100 positive axons revealed compara-
ble results [91]. While results comparable to autografting
demonstrate another promising method of peripheral nerve
regeneration, Ikeda et al. stated that the mechanisms of
regeneration are unclear meaning that further elucidation
of its methods is necessary to potentially allow for further
manipulation and improvements as needed.
The use of dental stem cells was considered through
the use of SHED cells seeded onto a “poly(e-caprolactone)/
gelatin nanofibrous nerve guide” to repair a 10mm artificial
sciatic nerve defect in Wistar rats [93]. The scaffold used in
this study was formed through electrospinning nanofibres of
PCL/gel compound to create a high surface area to volume
ratio allowing for improved cell adhesion. Analysis of func-
tional motor and sensory recovery as well as axonal regen-
eration revealed greater improvement in the experimental
group over any of the control groups. Histological analysis
revealed increased presence of neural cell markers and a
decreased expression of stem cell markers indicating that the
SHED were entirely capable of transitioning into neural stem
cells. The neural crest origin of dental stem cells is thought
to provide them with additional in vivo neural propensity
[93].
Dental pulp is known to contain both Schwann cells and
stem cells and therefore may possess many ideal properties
for nerve regeneration [94]. Sasaki et al. sought to explore the
regenerative properties of dental pulp cells in a craniofacial
setting.They designed amodel using dental pulp cells (DPCs)
suspended in a collagen gel which was infused into a 10mm
silicone tube. Nerve dissection was carried out producing a
bilateral 7mm gap in the buccal division of the facial nerve.
The resected stumps were then sutured into the tube and after
the designated time period the implanted tube was excised to
allow for analysis [94, 95].
Tubulation of dental pulp cells was to confer functional
myelinated axonal growth, improve recovery times, and pro-
ducemeasurable promotive levels of important neural growth
factors such as NGF, BDNF, and GDNF. This comparably
simple procedure showed that dental pulp cells have great
potential in neural regeneration, with bothDPSCs and dental
pulp derived Schwann and endothelial cells detected [94].
In later experimentation Sasaki sought to exclusively utilise
DPCs in the same model and carry out electrophysiological
and functional analysis. Analysis of facial palsy at the end
of the study revealed no significant differences between the
DPC and autograft group. Investigation of action potentials
revealed consistent electrophysiological results comparable
to autografting. Tubulation shows some promise as an effec-
tive therapy as evidenced by the studies discussed; however
conductive resorbable hybrid or biological polymer hybrids
are necessary in order to facilitate a one-step surgical proce-
dure [95].
A fascinating approach was utilised by Saito et al. where
they opted to manipulate the stem cell through culture to
form a 3D construct without the need for external mate-
rials. They performed thorough enzymatic extraction and
purification of skeletal-muscle stem cells (SK-mSCs) while
maintaining maximal cellular contacts. The resulting SK-
mSC sheets were then centrifuged to form a 3D pellet. Saito
et al. also opted to evaluate the pellets to regenerate a facial
resection model, consisting of a “large facial nerve-blood
vessel network deficit” encompassing both the buccal and
zygomatic branches of the facial nerve [96]. The engrafted
construct bridged the defect regenerating functioning myeli-
nated axons along with supportive cell types. SK-mSCs were
also found to have an angiogenic propensity generating
smoothmuscle cells and endothelial cells. Physiological nerve
bridging without specific guidance was believed to be due to
the spatial release of neurotrophic factors by resected stumps
during early SK-mSC differentiation [96]. This regenerative
model seems to hold huge promise in cases of craniofacial
cancers. Wide tumour resections in the head and neck
region are associated with marked decrease in quality of life;
therefore any early promising studies targeting multitissue
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defects in the craniofacial area are vital and should be
progressed upon.
Tissue regeneration must always occur in a controlled
directional fashion; nowhere is this more uniquely evident
than in neural regeneration. Future scaffold design and
tissue engineering efforts need to concentrate on inductive
strategies for improved directional proliferation over criti-
cal sized defects. Currently evidenced in the literature are
several extremely promising stem cell sources with excellent
neurogenic propensity. Dental stem cells are no exception
to this group, displaying excellent neurogenic potential, low
morbidity of harvest, and neuroprotective effects. DPSCs
have shown significant aptitude, displaying the ability to
ameliorate awide variety of neural defect locations such as the
optic nerve, spinal cord, and central nervous system [97–99].
Such widespread applications only act to further highlight
their promise in this field.
5. Stem Cell Therapy for Sensory Regeneration
5.1. Early Steps in Taste Regeneration. Most loss in taste is due
to neurological damage to the lingual and glossopharyngeal
nerve; however certain conditions can also damage the taste
buds leading to ageusia. Loss of taste and indeed any sense
comes with certain loss of life quality. A study carried out by
Takeda et al. discovered the taste bud progenitor cell which
was identified by expression of the Lgr5 receptor; they then
demonstrated that this type of cell could give rise to taste
buds on the anterior and posterior sections of the tongue
and demonstrated the cell’s ability to regenerate posterior
taste buds after CN-IX transection [100]. While this may be a
promising discovery, this is the first reported regeneration of
taste buds and more research is needed to quantify the value
of this report.
5.2. Stem Cell Based Regeneration of Corneal and Retinal
Tissues. Possibly themost damaging sense to lose is sight.The
cornea is themost exposed part of the eye and it ismost prone
to injury from thermal or chemical trauma. If the limbus
of the cornea is damage, there is significant epithelialisation
which leads to stromal scarring and corneal opacity. A study
by Rama et al. collected autologous limbal stem cells (LSCs)
from the uninjured contralateral eyes of burn patients. Their
results showed that LSCs can restore a transparent cornea
with visual acuity in burn patients. However the efficacy
of this treatment is dependent on % p63 bright cells as
patients with received cultures with >3% p63 cells had a 78%
success rate while those with cultures of <3% p63 cells had a
success rate of less than 11% [101]. Therefore perhaps future
studies should consider methods of optimising the culture
and expansion conditions of limbal stem cells to isolate a
suitable concentrate p63 expressing cells.
Another trial investigating corneal regeneration opted
to utilise oral mucosal sheets in corneal reconstruction.
Nishida et al. discuss how oral mucosa expresses keratin 3
similarly to the cornea; the excision of such tissue presents
very low morbidity and the transplantation of autologous
tissue avoids immunity complications in conditions such as
Stevens-Johnson syndrome and ocular pemphigoid. Each of
these qualities combined with an elevated native epithelial
stem and progenitor cell population make it an attractive
tissue choice. The oral mucosal tissue was cultured to trans-
form into autologous epithelial cell sheets preimplantation.
Transplanted oral epithelial cell sheets integrated into the
corneal tissues well, becoming transparent and smooth.
Visual acuity was described as improving “remarkably” and
therewere no postoperative complications.This trial seems to
have presented a very suitable noninvasive, viable treatment
for reconstructing the ocular surface [102].
Irreversible blindness may also be caused by photorecep-
tor loss in retinal disease. The retina proves to be difficult
to provide regenerative care for as stem cell therapy had
proved relatively ineffective. MacLaren et al. were able to
demonstrate that an adult retina can integrate with rod
photoreceptor progenitor cells expressingNrl [103]. From this
Pearson et al. developed a potential treatment strategy to
improve vision via photoreceptor transplantation. Nrl-GFP+
rod precursors were extracted from postnatal mice which
were then transplanted into a-transducin rod negative Gnat1
mice. Following integration of the rod precursors, analysis
of vision revealed that the Nrl-GFP1 transplantation group
was photosensitive with improved visual acuity and displayed
visually guided behaviour. While in the early stages, this
treatment holds huge potential in the future treatment of
retinal disease [104].
Current research is beginning to recognise stem cell
markers which identify promising stem cell and transit-
amplifying populations for regeneration of ocular tissues.
Current treatments for severe corneal damage involve trans-
plantation which require donor tissue and suffer relatively
high risks of rejections. Treatment options are similarly
lacking for retinal diseases. There is an obvious apparent
need for efficient conventional treatment for such ophthalmic
conditions and early research shows that stem cell therapy has
the potential to deliver. Interestingly Nishida et al. were able
to demonstrate that dental stem cells may hold regenerative
capabilities in ocular tissues. This relatively simple treatment
model displayed high efficacy and with further development
could present some really attractive results.
6. Regeneration of Exocrine Glands
In the craniofacial region exocrine glands such as the lacrimal
or salivary glands carry out essential secretory functions.
Loss or absence of function of these glands is associated
with lower life quality and numerous difficulties. Exocrine
glands are vulnerable to the damaging effects of radio-
therapy but can also be damaged via trauma, disease, or
congenital abnormality. Current treatments to restore the
loss of secretion associated with gland hypofunction involve
the use of artificial substitutes or stimulants (muscarinic
receptor agonists) both of which may be costly and/or have
undesirable side effects [105, 106].
6.1. Stem Cell Therapy to Improve Salivary Function. Salivary
gland reconstruction may be needed due to trauma, radio-
therapy, and tumour excision. Conditions such as xerostomia
or Sjo¨grens syndromes are associated with considerable
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morbidity such as an increased caries incidence, difficulty
in mastication, speech, and swallowing as well as burn-
ing mouth syndrome. Current treatments are noncura-
tive. Nanduri et al. transplanted cells carrying the pos-
sible stem/progenitor markers, “c-kit, CD133, CD49f, and
CD24,” into irradiated mice’s salivary glands [105]. The mice
transplanted with CD133 and c-kit displayed a significant
increase in salivary output when compared to the control
irradiated mice [105]. While this study showed promise in
using a local stem cell population to improve salivary output,
there exist some flaws. Radiotherapy can damage progenitor
cell populations, preventing the harvesting of autogenous
stem cell populations. This study could provide methods
of providing treatment options for cases of salivary gland
hypofunction caused by factors other than radiotherapy but
may not possess much clinical feasibility.
A study that may possess greater efficacy was that car-
ried out by Lim et al. which utilised the multipotency of
ASCs. They set out to explore whether systemic delivery
of xenogeneic ASCs can mitigate the deleterious effects of
irradiated salivary glands in an animal model. ASCs were
obtained from cultured surplus banked stem cells. ASCs
were then injected into the tail vein of the control and
the irradiated C3H female mice immediately after radiation.
Salivary output in the ASC group was shown to have a
statistically significant improvement on control irradiated
group. This improvement in the ASC group was also seen
at a molecular level with statistically significant rises in both
mucin and amylase production over the control irradiated
group. Analysis of the number of TUNEL-positive apoptotic
cells at 4 weeks revealed that ASCs have a significant effect
as to reducing tissue damage [107]. Analysis also revealed
that the human ASCs were capable of transdifferentiating
in salivary gland cells. However it was agreed by Lim et al.
that the improvement in salivary gland function was most
likely due to the paracrine signalling effects of bioactive
factors released from the ASCs and not due to their direct
transdifferentiation [106]. More conclusive animal models
need to be developed and more efficient methods of cell
delivery need to be established for more effective results to
be obtained.
Early studymodels utilising stem cell therapy have shown
promise and more recent studies attempting to generate a
bioengineered salivary gland from isolated epithelial and
mesenchymal stem cells display significant salivary flow and
recovery of dry-mouth symptoms [108]. Our current research
has not displayed any procedures using dental stem cells in
salivary gland regeneration yet.This is surprising due to their
ease of access and shared craniofacial origin; hopefully future
studies will opt to include dental stem cells.
6.2. Lacrimal Gland Regeneration. The lacrimal gland is
an essential component to complete vision. The lacrimal
gland produces a serous secretion to maintain the tear film,
manage the transparency of the cornea, and ensure that
superior quality images are transmitted to the retina [95].
Similar to the salivary glands any disturbance to the lacrimal
gland function termed “dry eye syndrome” can have some
severe chronic effects causing discomfort and eventual loss
of visual acuity [109]. Current treatments remain supportive
and noncurative, consisting mostly of long-term frequent
administration of lubricating eye drops. More advanced
treatments such as autotransplantation of salivary glands
are also showing inadequate success. Analogous to salivary
glands, lacrimal glands are commonly damaged or disrupted
via radiotherapy, trauma, systemic conditions, and so forth.
Regenerative medicine may be able to provide a supportive
treatment option to restore function [109].
Hirayama et al. proposed a more complete treatment
consisting of a bioengineered lacrimal gland germ to restore
function in lacrimal gland defect mice. The bioengineered
lacrimal gland germwas fabricated through obtaining ED16.5
mice lacrimal gland germs and then separating the germ
into respective epithelial and mesenchymal cell types. These
cell types were then reconstituted into the appropriate germ
morphology using a method of 3D cell manipulation. The
extraorbital (as opposed to the intraorbital) lacrimal gland
was excised in 7-week-old mice and the bioengineered
lacrimal gland was inserted and connected to the original
duct via a polyglycolic acid monofilament [110]. Histological
analysis revealed correct 3D shaping with innervation follow-
ing transplantation. Analysis of tear secretion after adminis-
tration of pilocarpine revealed that the bioengineered mouse
group showed no significant statistical difference in secretion
rates to a controlmouse. Analysis of tear components showed
that the bioengineered lacrimal gland was entirely capable
of producing appropriate tear proteins. Analysis of the
corneal surface too showed that the bioengineered graft mice
matched the control mice, proving that the bioengineered
lacrimal gland model is capable of ensuring a healthy ocular
surface.This study demonstrated an experimental model and
treatmentwhich could have potential as a surgicalmethod for
the treatment of dry eye disease. While this method provided
correct physiological function, it is limited by its success rate
of engraftment, its feasibility, and the invasiveness of the
procedure [110].While a long way from clinical trials, current
studies into lacrimal gland and organ regeneration present
hopeful results and stem cell therapy could provide many
future treatment modalities.
7. Frontier of Stem Cell Therapy,
What Does the Future Hold?
The future of stem cell therapy in the craniofacial medicine is
bright and optimistic with huge opportunities for improve-
ment and a vast array of upcoming possibilities. In future
years to come, further research will reveal new approaches
towards regeneration while expanding our knowledge of
the current field, hopefully allowing for exceptional clin-
ical results. Our developing comprehension of signalling
pathways, cell manipulation, and stem cell characteristics
may allow us to circumvent current treatment morbidities
and discover methods of ameliorating conditions considered
incurable. Most current studies on animal models evaluate a
single promotive stem cell type in healing. Future studiesmay
be able to proceed with multiple cell types and manipulate a
wide variety of introduced and native factors over extended
periods of time to create the ideal signalling network for
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optimum regeneration. However before breakthroughs like
this are made it is essential that the action of these molecules
inside signalling pathways be fully comprehended to ensure
that there are no potential negative side effects. Future
research into growth factors must also overlap with tissue
engineering and evolving scaffold design so that drug kinetics
can be more efficiently controlled and monitored. Despite
the current shortcomings, it seems without doubt that small
promotive factors will partake in the future of regenerative
medicine [111].
Stem cell exploration is revealing an exciting tomorrow
where grievous traumatic injuries can be treated safely with
no loss of function or aesthetics. Huge breakthroughs have
been made in the field in the past decade particularly with
the generation of iPSCs from adult human somatic cells
types [112, 113]. The reprogramming of adult human cells
into various different stem and progenitor cell types has huge
implications in the field of stem cell therapy as it solves
many long-term problems related to other stem cell types.
As iPSCs are patient specific, they are not burdened by
immunological defences unlike stem cells from allogenic or
xenogenic sources. iPSCs are also benefited by their potential
abundance and versatility as they can be harvested easily
and cheaply to develop into a wide variety of different tissue
cell types [112, 113]. This ability to differentiate to several
different tissue types is ideal for craniofacial reconstruction as
there is a wide variety of tissue types in need of regeneration
following such a procedure. Research into iPSCs is still only
scratching the surface; future experimentation and research
should reveal enhanced results and their potential will no
doubt continue to be exploited and expanded [113].
The generation of iPSCs was only possible through the
mechanisms of gene therapy, an equally promising tool in the
field of craniofacial regeneration. Aside from reprogramming
somatic cells into stem cells, gene therapy has numerous other
possibilities in the field of regenerative medicine.
(1) Head and neck cancers: research into gene therapy
has resulted in the formation of oncolytic viruses
which specifically target replicating tumour cells to
induce cell death and a corresponding decline in
tumour size. While this form of treatment may not
be directly involved with the reconstructive process,
it could have a definite impact on the scale of recon-
struction/regeneration needed [114].
(2) Mineralised tissue regeneration: gene therapy re-
search has revealed some fruition in mineralised tis-
sue regeneration through controlled spatial activation
of osteogenic genes and the resulting upregulated
proteins. This method of growth factor and protein
delivery can greatly increase regeneration especially
when combined with other regenerative techniques
such as the introduction of stem cells [4, 114].
(3) Salivary gland function: following ablative radio-
therapy, certain medications, and so forth, salivary
glands often cease to function properly. Using gene
therapy, aquaporins can be introduced into the ductal
epithelial cells allowing for increased fluidmovement.
Human clinical trials using this therapy have been
found to be promising, with subjective improvements
in xerostomia and relieved symptoms [114, 115].
Although large-scale craniofacial reconstruction is not cur-
rently benefitted by gene therapy, its applications of con-
trolled protein production and tissue repair coordination
make it an invaluable tool in the advancement of regeneration
and will present as an adjunctive therapy to stem cell based
treatments [114].
Even the development and advancement of available
technologies are allowing us to produce scaffolds and
other tissue engineering materials with superb biocom-
patibility and mechanical properties. Future biomaterials
and scaffold designs are assured to increasingly mimic
the extracellular matrix and further engage and enhance
stem cell activity providing yet another boost to this
field.
This is a brief view of some of the most promising
methods, techniques, or materials set to improve and expand
the field of stem cell therapy. The future for stem cell
therapy is not only bright in terms of upcoming treatment
options for clinicians. New laws and regulations regarding
stem cells and gene therapy approaches are allowing for
new avenues of research. This sort of government back-
ing along with financial interest from the private sector
will ensure continued prosperity in the research of new
treatments. Research is even being carried out on the fea-
sibility of current regenerative techniques showing huge
private marker backing [116]. Research into regenerative
medicine is now also reaching the phases of clinical trials
in many cases which will hopefully result in the introduc-
tion of new effective regenerative treatments in the near
future.
8. Conclusion
Throughout this paper, there have beenmany demonstrations
of the ground-breaking research, studies, and trials into
future and potential stem cell treatments applications for
a wide range of conditions, injuries, and defects. Areas of
stem cell research show possible promising treatments in
regard to nearly every craniofacial structure. Table 4 presents
a summary of the especially promising stem cell types
presented in this paper.
Dental stem cells are an upcoming source of stem cells in
regenerativemedicine. Current evidence shows a broad range
of promising evidence in regenerating craniofacial tissues.
Their use has shown significant improvement in function and
healing rate and they are associated with much lower rates of
harvest morbidity and postoperative discomfort. Ultimately
future research will determine definitive uses of dental stem
cells within the field of stem cell therapy; however it seems
that their future is optimistic.
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Table 4: This table presents a general summary of target tissues or organs in need of superior regenerative solutions and the corresponding
stem cell types evidenced with feasible regenerative potential.
Tissue/tissues to be
regenerated
Promising stem cell sources to be used in isolation
or conjunction References
Bone BM-MSCs, ASCs, DPSCs, SHED
[24, 26, 34, 36, 37, 40, 42, 44, 46, 49, 50, 54, 56, 62–
65, 71–73, 78, 81, 83–85, 91, 93, 94, 96, 101–104, 106, 117]
Cartilage PDLSCs, BM-MSCs, TMJ-SCs
Tooth PDLSCs, BM-MSCs, iPSCs, and tooth progenitorcells
Oral mucosa Oral mucosa stem cells and iPSCs
Periodontium PDLSCs and iPSCs
Skin Embryonic MSCs, LGR 6+ SCs, PBSCs, and ASCs
Fat ASCs
Muscle Mesoangioblasts, iPSCs, DPSCs, and muscle stemcells
Nerve iPSCs, SHED, DPSCs, SK-mScs
Cornea LSCs, and oral mucosa epithelial stem cells
Retina NRl rod photoreceptor progenitor cells
Salivary gland CD133/c-kit expressing SCs and ASCs
Lacrimal gland ASCs
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